ArticleJournal of family medicine and primary care2026
Assessing cognitive impairment in Saudi Arabian diabetes patients: A cross-sectional study in Aseer region.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: According to the American Diabetes Association, diabetes mellitus is a collection of metabolic illnesses marked by hyperglycemia brought on by deficiencies in either insulin action or secretion or both. Long-term heart, blood vessel, kidney, eye, and nerve dysfunction has been associated with chronic hyperglycemia. The gradual decline in mental capacity and cognition, specifically in verbal memory, processing speed, and executive functions, is one of the most recent complications of diabetes. Methods: This cross-sectional study (August-December 2023) in the Aseer region included over 246 diabetic patients aged ≥18 years with type 1 or 2 diabetes. Data were collected via electronic questionnaires assessing demographics, clinical factors, cognitive function (MoCA), and diabetes-related distress (DDS-17). Ethical approval was granted by King Khalid University's Research Ethics Committee. Analyses using SPSS v31 included descriptive, correlation, and multivariate regression tests to identify risk factors. Results: The results indicated a statistically significant but weak negative correlation between age and cognitive impairment scores (r = -0.093, Conclusion: Diabetes is closely associated with a higher risk of cognitive impairment. In this study, gender, age, HbA1c, marital status, and residence showed significant links to cognitive scores. Effective diabetes control helps reduce cognitive decline as higher HbA1c levels were strongly associated with greater impairment severity. Ongoing research is vital to identify high-risk individuals and develop targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.